News / Business
Biggest Losers on Thursday (BLUD, BEBE, AFFY)
Biggest Losers on Thursday
Immucor,
Inc. (NASDAQ:BLUD) is the biggest loser and slumped 18.70% to
$16.62 after late
Wednesday the company trimmed its 2011 outlook.
The company said that it now sees its
fiscal 2011 earnings of $1.08 to $1.18 a share and revenue to be $320 million
to $332 million, compared to its previous outlook of $1.23 to $1.29 per share
and revenue of $345 million to $355 million.
You can Subscribe to these Free Stock Alerts by visiting: http://www.PennyStockPickReport.com
Analysts currently estimates $1.28 a
share on revenue of $352.2 million.
The company said it earned to $21.4
million, or 30 cents a share in its fiscal first-quarter, up slightly from
$21.3 million, or 30 cents a share, in the year-earlier quarter.
Revenue grew to $83.6 million from
$83.1 million.
Analysts were expected the company to
report earnings of 30 cents per share on revenue of $85.02 million.
Immucor, Inc. (Immucor) develops,
manufactures and sells a line of reagents and automated systems that detect and
identify certain properties of the cell and serum components of human blood for
the purpose of blood transfusion.
bebe
stores, inc. (NASDAQ:BEBE) slid 10.60% to $6.25 on higher than the average volume after
the company the reported lower than
estimated sales for its first quarter.
This morning, the company said that sales
slid 7% to $111.9 million for the quarter ended Oct 2, comparing to analysts estimates
of $118.2 million.
On the other hand, same-store sales
also declined by 4.70% for the month of September. Missing the analysts estimates.
Shares of BEBE have not done much this
year and has given a flat return.
bebe stores, inc. designs, develops and
produces a line of contemporary women's apparel and accessories. The Company’s
product offering includes a range of separates, tops, dresses, active wear and
accessories in the lifestyle categories, such as career, evening, casual and
active.
Affymax,
Inc. (NASDAQ:AFFY) is another big loser and lost 8% to $5.95 after the company
said that it has received a decision from the arbitration panel reviewing its
dispute against certain subsidiaries of Johnson and Johnson (JNJ).
The panel has determined that Affymax and JNJ are co-owners of certain intellectual property, including U.S. patent numbers 5,773,569, 5,830,851, 5,986,047, among others related to erythropoietin receptor agonists.
The decision concluded that JNJ is sole
owner of JNJ’s U.S. patent number 5,767,078 (‘078) and certain other related
patents and patent applications in Europe, Japan, Canada and Australia.
About http://www.PennyStockPickReport.com Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on top stocks, most active movers, top gainers, penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below
